Investing
The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.
Plexāā, maker of the Bloom medical device for breast surgery, scores $4.5 million in funding.
The spin-off company is expected to rake in almost $2 billion in revenue this year.
The company offers mental healthcare for children and their families and will use the funds to expand its reach.
The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications.
The company will use the funds to hasten product development, engineering and go-to-market efforts to meet market demand.
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
The Series E funding comes four months after the company secured $250 million in a Series D round.
Funding from the venture capital firm's Customer Value Fund will allow Commure to accelerate its expansion in healthcare without ownership dilution.
The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year.